Location: Home
  • search
  • go
  • Relate News
  • 1/13/2010Sinovac receives fifth H1N1 vaccine order from the Chinese government ...
  • 1/12/2010WHO warns against boom for elective C-sections in China
  • 1/12/2010Invida Group launches branded dermatological drugs in Asia
  • 1/12/2010Initial clinical data shows ZADAXIN'S ability to enhance response to H...
  • 1/12/2010Public hospital reform "basically" ready and pending State C...
  • 1/11/2010Pharmaron Holdings acquires Bridge Labs to become an integrated CRO
  • 1/11/2010Japanese drug wholesalers begin to penetrate the Chinese market
  • 1/11/2010Qiagen partners with Wuxi AppTec to support biomarker development in A...
  • 1/11/2010Jiangsu hands out US$1.8M grant for stem cell R&D
  • 1/8/2010MOH announces priorities for health work and public hospital reform in...
  • 1/8/2010Tianjin Pharmaceutical Group fails to close merger talk with Dongsheng...
  • 1/8/20103SBio files CTA application for Feraheme
  • 1/8/2010Study shows China a leader in regenerative medicine research
  • 1/8/2010Top executive at BMP Sunstone resigns
  • 1/8/2010Lundbeck faces EU antitrust probe
  • 1/8/2010Bristish scientists develop vaccine treatment for Leukemia
  • 1/7/2010China Medicines receives US$70M in private placement from OEP
  • 1/7/2010NDRC to halt bulk vitamin C expansion wave in China
  • 1/7/2010CAMS announces phase III trials of its novel macrolide antibiotic
  • 1/6/2010Essential drug system to be implemented in selected grade II and III h...
  • 1/6/2010Rural cooperative medical scheme covers 94% of rural population
  • 1/6/2010Xinchang Pharma passes USFDA inspection for bulk antimalaria drugs
  • 1/6/2010China Aoxing Pharma completes phase II trials of novel PD drug
  • 1/5/2010More details emerge on the negotiation mechanism of the NDRL
  • 1/4/2010MOH to introduce plan for public hospital reform trials soon
  • 1/4/2010MOC takes over industry administration of the Chinese pharma distribut...
  • 1/4/2010MOH issues clinical pathways for two blood diseases
  • 12/30/2009MOH introduces clinical guidelines and formulary for essential drugs ...
  • 12/30/2009MSD cuts price of Zocor for higher market share
  • 12/30/2009Ranbaxy sells majority stake in Guangzhou JV to HNG Chembio
  • Page:295/333 Total number of articles:9989: [First][<<] [293] [294] [295] [296] [297] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group